When a friend or loved one shows signs of alcohol addiction, it can be difficult to know how to help. Alcohol addiction, also known as alcohol use disorder (AUD), is a disease that affects the brain ...

Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

Nick Padlo’s addiction to alcohol and drugs didn’t happen overnight. “I was using them as a tool to cope with depression and anxiety,” says the recovered addict and founder of Sophros Recovery in ...

Research is quickly catching up. In the last few years, studies have linked GLP-1 drugs like Ozempic and Wegovy with fewer ...

Patients on GLP-1 drugs report losing cravings for addictions, ranging from opioids to gambling, prompting researchers to examine whether these diabetes and obesity medicines can curb addiction ...

When she was in her 40s Jenny Teeters had a serious secret drinking problem, but, she says, her success hid it exceptionally well for years. At one point she managed a high six-figure tech job, raised ...

SIOUX FALLS, S.D. (KELO) – In the face of rising addiction rates, the community triage center, The Link, is providing a safe space for people facing substance use and alcohol addiction recovery.

Studies suggest GLP-1 drugs like Semaglutide and Tirzepatide may help reduce cravings for alcohol, opioids, and nicotine. Researchers say these medications influence the brain’s reward system, ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

I was addicted to alcohol for more than 15 years. What started as binge drinking in high school and college became a pattern of blackouts, emergency room visits, regret and shame. As peers grew up and ...

GLP-1 medications may quiet the brain signals behind addiction, reducing substance use disorders and overdose risk across ...